After analyzing the blood samples of 33 severe and critical type ill COVID-19 patients, Wei Haiming’s team found that after novel coronavirus infection, T cells were overactivated to produce granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-6 (IL-6). Here, IL6 is linked to COVID-19.